← All decks

Dermatology

Neurofibromatosis and Tuberous Sclerosis Complex

Built from Dermatology, 5th Edition

What’s inside

6 sections · 165 slides

  1. 01

    Neurocutaneous Disorders: Overview

    Phakomatoses, autosomal dominant inheritance, and the dermatologist's role in diagnosis

    • What is a phakomatosis?
    • Classifying neurofibromatosis

    2 slides

  2. 02

    Neurofibromatosis Type 1

    Also called von Recklinghausen disease

    • Neurofibromatosis type 1: key features
    • History of neurofibromatosis type 1
    • Epidemiology of neurofibromatosis type 1
    • The NF1 gene and neurofibromin
    • Genotype-phenotype patterns in NF1
    • The tumor microenvironment and neurofibroma formation
    • Mechanism: how neurofibromin loss drives growth
    • Clinical features of NF1: overview
    • Major clinical features of neurofibromatosis type 1
    • Major clinical features of neurofibromatosis type 1 (continued)
    • Major clinical features of neurofibromatosis type 1 (continued)
    • Major clinical features of neurofibromatosis type 1 (continued)
    • Major clinical features of neurofibromatosis type 1 (continued)
    • Cafe-au-lait macules
    • Cafe-au-lait macules and freckling
    • Neurofibromas: the tumor that names the disease
    • Multiple cutaneous neurofibromas
    • Less common cutaneous neurofibroma patterns
    • Neurofibroma subtypes at a glance
    • Subcutaneous neurofibromas
    • Plexiform neurofibromas
    • Natural history of plexiform neurofibromas
    • Malignant transformation of plexiform neurofibromas
    • Juvenile xanthogranuloma and leukemia risk
    • Vascular findings: nevus anemicus and glomus tumors
    • Lisch nodules of the iris
    • Choroidal abnormalities
    • Mosaic (segmental) neurofibromatosis type 1
    • Optic pathway gliomas
    • Other CNS tumors and brain MRI findings
    • Learning, behavior, and seizures
    • Skeletal manifestations of NF1
    • Cardiovascular manifestations of NF1
    • Timeline of clinical features developing in NF1
    • Why the order of findings matters
    • Pathology of NF1 skin lesions
    • Pathology of malignant peripheral nerve sheath tumor
    • Diagnosing NF1: classic and revised criteria
    • Revised diagnostic criteria for NF1 and mosaic NF1
    • Revised diagnostic criteria for NF1 and mosaic NF1 (continued)
    • Approach to a child with 6 or more cafe-au-lait macules
    • How reliable are cafe-au-lait macules alone?
    • Molecular testing for NF1
    • Segmental look-alikes of mosaic NF1
    • Legius syndrome
    • Other entities in the differential diagnosis
    • Disorders associated with multiple cafe-au-lait macules
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Disorders associated with multiple cafe-au-lait macules (continued)
    • Neurofibromatosis type 2: how it differs from NF1
    • Key features of neurofibromatosis type 2
    • McCune-Albright syndrome
    • Plexiform neurofibroma vs congenital melanocytic nevus
    • Managing NF1: the general approach
    • Evaluation and management of patients with NF1
    • Evaluation and management of patients with NF1 (continued)
    • Treating the skin lesions of NF1
    • Watching for malignant transformation
    • Targeted drug therapy for NF1 tumors
    • NF1 patient resources
    • 02b
    • Axillary lentigines and cafe-au-lait macule
    • Multiple lentigines, cafe-au-lait macules, and neurofibromas
    • Large cafe-au-lait macule with neurofibromas and Crowe sign
    • Multiple neurofibromas with lentigines
    • Neurofibromas of the areola
    • Plexiform neurofibromas: sagging bag-like plaques
    • Plexiform neurofibroma with 'bag of worms' texture
    • Plexiform neurofibroma misdiagnosed as a birthmark
    • Plexiform neurofibroma presenting as a hyperpigmented plaque
    • Plexiform neurofibroma in a child

    77 slides

  3. 03

    Tuberous Sclerosis Complex

    Also known as Bourneville-Pringle disease or 'epiloia'

    • Tuberous sclerosis complex: key features
    • The two TSC genes
    • History of tuberous sclerosis complex
    • Epidemiology of tuberous sclerosis complex
    • The TSC genes and their protein products
    • Mechanism: how TSC gene loss drives hamartomas
    • Which gene, which severity?
    • Clinical features of TSC: overview
    • Major clinical features of tuberous sclerosis complex
    • Major clinical features of tuberous sclerosis complex (continued)
    • Hypomelanotic macules
    • Confetti (guttate) macules
    • Cafe-au-lait macules in TSC
    • Facial angiofibromas
    • Fibrous cephalic plaque
    • Shagreen patch (collagenoma)
    • Ungual fibromas
    • Molluscum pendulum and oral findings
    • Retinal hamartomas
    • Order in which cutaneous features of TSC appear
    • Infantile spasms
    • Intellectual and behavioral effects (TAND)
    • Subependymal nodules and SEGA
    • Cortical dysplasia and tubers
    • Cardiovascular manifestations of TSC
    • Renal manifestations of TSC
    • Pulmonary and other manifestations
    • Where each TSC organ system is affected
    • Pathology of TSC skin lesions
    • Pathology of the shagreen patch
    • Diagnosing tuberous sclerosis complex
    • Diagnostic criteria for tuberous sclerosis complex
    • Approach to an infant with 3 or more hypomelanotic macules
    • Genetic testing yield in TSC
    • Other syndromes that mimic TSC skin findings
    • Hypopigmented and shagreen-patch look-alikes
    • Managing tuberous sclerosis complex
    • Evaluation and management of tuberous sclerosis patients
    • Evaluation and management of tuberous sclerosis patients (continued)
    • mTOR inhibitors: a shared systemic therapy
    • Sun protection and topical therapy for angiofibromas
    • Evidence for topical sirolimus
    • TSC patient resources
    • 03b
    • Ash leaf macules
    • Confetti and polygonal hypomelanotic macules
    • Facial angiofibromas and fibrous plaque
    • Facial angiofibromas in an adult
    • Fibrous plaque of the forehead
    • Large fibrous cephalic plaque
    • Shagreen patch with an ash leaf macule
    • Shagreen patch
    • Collagenoma with a leather-like surface
    • Multiple ungual fibromas
    • Longitudinal red streaks ('red comets')
    • Ungual fibromas of the toes
    • Shagreen patch histology stains
    • Calcified subependymal nodules on cranial CT

    58 slides

  4. 04

    Riccardi's Historical Classification

    How the seven original NF subtypes map onto today's understanding

    • Why Riccardi's scheme still matters
    • Riccardi's classification of neurofibromatosis

    2 slides

  5. 05

    Summary

    NF1 and TSC side by side

    • NF1 vs TSC: cutaneous hallmark features
    • NF1 vs TSC: shared disease logic
    • Key takeaways

    3 slides

  6. 06

    References

    Source citations from this chapter

    • References
    • References (continued 2)
    • References (continued 3)
    • References (continued 4)
    • References (continued 5)
    • References (continued 6)
    • References (continued 7)
    • References (continued 8)
    • References (continued 9)
    • References (continued 10)
    • References (continued 11)
    • References (continued 12)
    • References (continued 13)
    • References (continued 14)
    • References (continued 15)
    • References (continued 16)
    • References (continued 17)
    • References (continued 18)
    • References (continued 19)
    • References (continued 20)
    • References (continued 21)
    • References (continued 22)
    • Dermatology, 5th Edition (2-Volume Set)

    23 slides